Categories: HealthcareNews

Seoul to Host 1,040㎡ ‘Seoul Pavilion’ at CES 2025: “Advancing Global Success for Seoul Startups”

SEOUL, South Korea, Dec. 15, 2024 /PRNewswire/ — The Seoul Metropolitan Government announced on December 9 that it will operate its largest-ever exhibition space for Seoul-based startups at CES 2025, the world’s largest consumer electronics and ICT trade show. The event will run from January 7 to 10, 2025, in Las Vegas, showcasing cutting-edge technologies from emerging companies worldwide.

The “Seoul Pavilion,” covering 1,040㎡ at Eureka Park, CES’s startup-focused exhibition zone, represents a 50% expansion from last year. It will feature more startups and award-winning companies than ever before, underscoring Seoul’s growing presence in the global tech ecosystem since its debut at CES 2020.

The pavilion will spotlight Seoul-based AI, lifestyle, and healthcare startups, offering opportunities for investor matching, on-site competitions, and promotional events. Participating companies will receive comprehensive operational support, including booth setup, innovation award consulting, buyer matchmaking, on-site IR presentations, and media promotion.

This year, 104 startups from 16 organizations, including three key Seoul districts (Gangnam, Geumcheon, and Gwanak), five startup support agencies (Seoul Business Agency, Seoul Biohub, and Seoul AI Hub), and eight major universities such as Yonsei, Chung-Ang, and Sogang, will participate.

Each startup will be matched with a student supporter from these universities, with 103 highly skilled students offering on-site exhibition assistance, business meeting support, and event management help.

A record 21 participating startups have already secured CES 2025 Innovation Awards, presented annually by the Consumer Technology Association (CTA) to recognize technological innovation and product excellence. Notable awardees include Leadpoint System, Apollon, GenGenAI, Otiton Medical, and STUDIO LAB.

To prepare for CES 2025, the Seoul Business Agency held a launch ceremony on November 29 at Sogang University, gathering representatives from participating companies and support organizations. The event included networking sessions, exhibition support briefings, and IT business workshops. Participating startups were paired with student supporters, beginning months of collaborative planning.

Hyun-woo Kim, CEO of the Seoul Business Agency, emphasized, “CES 2025 will be a crucial platform to showcase Seoul’s advanced technologies and thriving startup ecosystem. We are committed to supporting our startups, helping them expand into global markets and achieve lasting success.”

The Seoul Pavilion aims to strengthen the city’s role as a global tech hub by fostering cross-border partnerships and expanding international market access for its innovative startups.

View original content to download multimedia:https://www.prnewswire.com/news-releases/seoul-to-host-1-040-seoul-pavilion-at-ces-2025-advancing-global-success-for-seoul-startups-302332104.html

SOURCE Seoul Metropolitan Government

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

20 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

20 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

20 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

20 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

20 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

20 hours ago